Showing results (891-900 of 1,396) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 11, 2020
Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center StudyAnita Chawla, Filip Janku, Jennifer J Wheler, et al.
JCO Precision Oncology|September 11, 2020
Applying Precision Oncology Principles in Radiation OncologySophia C Kamran, Kent W Mouw
JCO Precision Oncology|September 11, 2020
Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIALJulia D Wulfkuhle, Christina Yau, Denise M Wolf, et al.
JCO Precision Oncology|September 11, 2020
Genomic Instability and TP53 Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor TreatmentEugene F Schuster, Pascal Gellert, Corrinne V Segal, et al.
JCO Precision Oncology|September 11, 2020
Precision Oncology in Sarcomas: Divide and ConquerRoberto Carmagnani Pestana, Roman Groisberg, Jason Roszik, et al.
JCO Precision Oncology|September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven OncologyJessica J Tao, Michael H Eubank, Alison M Schram, et al.
JCO Precision Oncology|September 11, 2020
Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate CancerSinja Taavitsainen, Matti Annala, Elisa Ledet, et al.
JCO Precision Oncology|September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With GlioblastomaBrian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.
JCO Precision Oncology|September 11, 2020
Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non-Small-Cell Lung CancerMichael A Pritchett, D Ross Camidge, Manu Patel, et al.
JCO Precision Oncology|September 14, 2020
Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker EvaluationMei-Yin C Polley, Edward L Korn, Boris Freidlin
Pageof 140